4.7 Review

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease

Pierre Garcia et al.

Summary: A key pathological process in Parkinson's disease is the transneuronal spreading of alpha-synuclein, but our study suggests that inclusion formation is not the major driver of neurodegeneration in the early stages. Instead, activated microglia, possibly through oligomeric alpha-syn, may play a key role in this process.
Review Pharmacology & Pharmacy

Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease

Hilary Grosso Jasutkar et al.

Summary: This article discusses various approaches to prevent and mitigate alpha-synuclein toxicity in Parkinson's disease, including clearing its aggregates, inhibiting its misfolding and aggregation, reducing its expression level, and enhancing cellular clearance mechanisms. It also discusses the therapeutics in development and the challenges and opportunities in the field.

PHARMACOLOGICAL REVIEWS (2022)

Article Multidisciplinary Sciences

Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning

Sharon Hassin-Baer et al.

Summary: This study aims to explore the possibility of developing a biomarker that can differentiate early-stage Parkinson's disease from healthy brain function using a combination of electroencephalography (EEG) event-related potentials (ERPs), Brain Network Analytics (BNA) technology, and machine learning (ML) algorithms.

PLOS ONE (2022)

Article Nutrition & Dietetics

Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease

Giuseppe Caruso et al.

Summary: Cognitive impairment is a significant public health problem associated with normal aging and neurodegenerative disorders. Dietary polyphenols, particularly phenolic acids, play an important role in healthy aging and the prevention of cognitive decline.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

A Novel NOX Inhibitor Treatment Attenuates Parkinson's Disease-Related Pathology in Mouse Models

Anurupa A. Ghosh et al.

Summary: This study evaluated the efficacy of a novel NOX inhibitor in Parkinson's disease (PD) models, and found that the compound improved cell viability, reduced ROS levels, and decreased protein aggregation. Both mouse models treated with the compound showed alleviated motor deficits and reduced protein aggregation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases

Mayssa Hachem et al.

Summary: This review focuses on the targeted delivery of DHA to the brain in different lipid forms and suggests future research directions. DHA is essential for neural development, learning, and vision, but deficiencies in cerebral DHA levels have been associated with neurodegenerative diseases. Understanding the role of DHA in brain transport and its beneficial effects in healthy conditions and brain disorders is crucial for the prevention and treatment of neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation

Gaetano Calabrese et al.

Summary: This article discusses the protein-protein interactions of aggregation-prone proteins related to neurodegenerative diseases, highlighting the impact of protein aggregation on cellular functions and the key networks regulating protein aggregation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Medicine, General & Internal

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind placebo-controlled phase 1a trial

Johannes Levin et al.

Summary: This study evaluated the safety and pharmacokinetics of an orally bioavailable compound anle138b in healthy subjects through a single ascending dose (SAD) and multiple ascending dose (MAD) study. The results showed that anle138b did not cause major adverse events at doses that achieved therapeutic exposure levels in a mouse Parkinson model. These findings suggest the need for further clinical trials of anle138b in patients with synucleinopathies.

EBIOMEDICINE (2022)

Review Cell Biology

Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches

Marija Vidovic et al.

Summary: Parkinson's disease (PD) is the second-most common neurodegenerative disorder and lacks disease-modifying therapy. Aggregation of alpha-synuclein (alpha-Syn) is closely associated with PD, and current therapeutic strategies primarily focus on targeting alpha-Syn using small molecules and peptides. Other approaches such as gene silencing, cell transplantation, and immunotherapy are also being explored.
Editorial Material Cell Biology

Editorial: Amyloid-Membrane Interactions in Protein Misfolding Disorders: From Basic Mechanisms to Therapy

Neville Vassallo et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Pharmacology & Pharmacy

The Many Roles of Lysophospholipid Mediators and Japanese Contributions to This Field

Yugo Takagi et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2022)

Review Biochemistry & Molecular Biology

Linking glycosphingolipids to Alzheimer's amyloid-ss: extracellular vesicles and functional plant materials

Kohei Yuyama et al.

Summary: This review summarizes the role of exosomal GSLs in Ass homeostasis in the pathology of Alzheimer's disease (AD) and the development of plant-type GlcCer as functional food materials to prevent AD.

GLYCOCONJUGATE JOURNAL (2022)

Article Clinical Neurology

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Johan Willem Smit et al.

Summary: This study investigated the safety, tolerability, and pharmacokinetics of UCB0599 in both healthy participants and participants with Parkinson's disease (PD). The results demonstrated that UCB0599 had rapid absorption and predictable pharmacokinetic properties, with no significant food effect observed. Co-administration with itraconazole affected the disposition of UCB0599, but did not impact its safety profile. Treatment-related adverse events were more common in PD patients receiving UCB0599, but were mostly mild to moderate in intensity and unrelated to dosage.

MOVEMENT DISORDERS (2022)

Article Biochemistry & Molecular Biology

Effects of Dietary Lysophospholipid Inclusion on the Growth Performance, Nutrient Digestibility, Nitrogen Utilization, and Blood Metabolites of Finishing Beef Cattle

Meimei Zhang et al.

Summary: This study evaluated the effects of dietary supplementation with lysophospholipids (LPLs) on the growth performance, nutrient digestibility, and antioxidant status of finishing beef cattle. The results showed that LPL supplementation improved average daily gain, nutrient digestibility, and antioxidant enzyme activity, while reducing cholesterol, triglyceride, and malondialdehyde levels in the blood of the cattle.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

The synaptic lipidome in health and disease

Ana Sofia Valles et al.

Summary: Maintaining homeostasis of lipid, protein, and carbohydrate metabolism is crucial for cell functions. The brain, with its high energy demands and unique synaptic features, relies on lipids for structural compartmentalization and synaptic transmission. Imbalances in lipid metabolism during perinatal and late adulthood periods can lead to developmental alterations and neurodegenerative diseases.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2022)

Article Medicine, Research & Experimental

Lysophospholipids-potent candidates for brain food, protects neuronal cells against α-Synuclein aggregation

Tatsuya Karaki et al.

Summary: This study demonstrates the inhibitory effect of a certain lysophospholipids (LPLs) species extracted from porcine liver decomposition product (PLDP) on alpha-Synuclein (alpha-Syn) aggregation. Lysophosphatidylcholine (LPC) 16:0, LPC18:0, LPC18:1, and lysophosphatidylethanolamine (LPE) 16:0 contained in PLDP-extracted lipids (PEL) were found to strongly inhibit alpha-Syn aggregation. These findings suggest the potential of PLDP-derived LPLs as effective therapeutic agents against alpha-Synucleinopathies.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Biology

Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases

Soonsil Hyun et al.

Summary: Neurodegenerative diseases are characterized by dysfunction of cognition and mobility, often caused by aggregates of misfolded proteins. Recently, targeted protein degradation using small molecules has emerged as a promising new therapeutic approach for these challenging diseases. Various technologies, such as molecular glues, have shown success in degrading disease-related proteins and may hold potential for the treatment of neurodegenerative diseases caused by protein aggregation.

LIFE-BASEL (2021)

Article Biochemistry & Molecular Biology

Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative

Edward Chau et al.

Summary: The study found that AM17 can not only inhibit the aggregation of alpha S monomers, but also disaggregate alpha S oligomers and fibrils, independent of copper ions. Resveratrol also showed similar inhibitory effects on alpha S aggregation only in the presence of copper ions.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective

Francois Le Guerroue et al.

Summary: Ubiquitin signaling plays a crucial role in neurodegenerative diseases, primarily associated with degradation signals. Decrease in quality control pathways with age may be a critical factor in the development of neurodegeneration.

CELL DEATH AND DIFFERENTIATION (2021)

Review Biochemistry & Molecular Biology

Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases

Juan Huang et al.

Summary: Neurodegenerative diseases, such as Alzheimer's and Parkinson's, involve progressive loss of neurons and are common in the elderly. Excessive microglial activation leading to neuroinflammation is closely linked to the onset and progression of these diseases. Natural products like resveratrol show therapeutic potential in modulating microglial polarization and controlling neuroinflammation in the treatment of NDs.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)

Review Pharmacology & Pharmacy

Advances in Oral Drug Delivery

Mohammed S. Alqahtani et al.

Summary: Oral route is the most common and preferred way of drug administration, due to its non-invasiveness and convenience. Factors affecting oral drug absorption include solubility, mucosal permeability, and stability in the gastrointestinal tract. Various pharmaceutical technologies like nanocarriers and micelles have been explored to improve oral drug absorption.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biotechnology & Applied Microbiology

Amyloid-Like Aggregation in Diseases and Biomaterials: Osmosis of Structural Information

Nicole Balasco et al.

Summary: The discovery of polypeptide chains' propensity to form amyloid-like aggregates with stability is crucial in understanding neurodegenerative diseases; self-assembling through cross-beta structure can lead to promising biomaterials; successful characterization of amyloid-like assemblies offers new prospects in biomaterial research.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Clinical Neurology

Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats

Nathalie Van den Berge et al.

Summary: Using a rat model, it was found that the propagation of alpha-synuclein pathology from the gut to the brain is more efficient in old rats, resulting in dysfunction of the heart and stomach similar to observations in patients with Parkinson's disease. Age was shown to be a crucial factor for the aggregation and propagation of alpha-synuclein, highlighting the importance of using aged animals in preclinical studies for better understanding of age-dependent interactions.
Article Biophysics

Strong inhibition of peptide amyloid formation by a fatty acid

Jon Pallbo et al.

Summary: The aggregation of peptides into amyloid fibrils is associated with diseases like Alzheimer's and Parkinson's. In a study examining the influence of the fatty acid linoleic acid on amyloid formation, it was found that even small amounts of this acid could significantly inhibit the fibrillation process of NACore, a model peptide. This inhibitory effect is attributed to the co-association of peptide oligomers and fatty acid aggregates in the early stages of the process, possibly shedding light on similar mechanisms occurring in vivo.

BIOPHYSICAL JOURNAL (2021)

Article Cell Biology

Adenine nucleotide translocase 2, a putative target protein for 2-carba cyclic phosphatidic acid in microglial cells

Tamotsu Tsukahara et al.

Summary: This study identified the interaction between a metabolically stabilized cPA derivative, 2ccPA, and ANT2 in microglial cells, showing its ability to inhibit apoptosis induced by phenylarsine oxide and improve cell survival.

CELLULAR SIGNALLING (2021)

Review Biochemistry & Molecular Biology

The role of amyloid oligomers in neurodegenerative pathologies

Cameron Wells et al.

Summary: Neurodegenerative diseases such as AD, PD, HD, and ALS are rooted in the activities of amyloid-like proteins, with monomeric proteins undergoing conformational shifts to facilitate aggregation and formation of solid fibrils. Oligomeric stages are key drivers of neuronal toxicity, and feedback within the pathway results in exponential acceleration of aggregation. The complex protein dynamics contribute to the late onset and accelerating progression of these disorders, affecting cellular interactions and environment. Targeting core elements of pathological progression may hold promise for future therapies.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Biochemistry & Molecular Biology

Small Molecule Fisetin Modulates Alpha-Synuclein Aggregation

Rita Rosado-Ramos et al.

Summary: The study found that fisetin has neuroprotective effects and modulates cellular pathologies related to Parkinson's Disease, reducing the formation of PD hallmark inclusions and increasing dopamine transporter levels.

MOLECULES (2021)

Article Clinical Neurology

Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis

Cristina Rosell-Valle et al.

Summary: The chronic modulation of the LPA/LPA receptors-signaling pathway in the brain plays a crucial role in regulating cognition and emotion, particularly through hippocampal-dependent mechanisms. Chronic C18:1 LPA infusion leads to antidepressant effects, improved memory, and enhanced hippocampal neurogenesis, while LPA(1-3) receptor antagonist disrupts memory and induces anxiety and depression-like behaviors.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Cell Biology

Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB

Tsui-Wen Chou et al.

Summary: This study reveals that preformed fibrils of alpha-synuclein induce pathogenic activation of human midbrain astrocytes, involving inflammatory responses, downregulation of phagocytic function, and conferral of neurotoxic activity. These effects are dependent on necroptotic kinases RIPK1 and RIPK3, but do not involve MLKL or necroptosis. The activation of astrocytes occurs through RIPK-dependent activation of NF-kappa B signaling, highlighting new roles for RIP kinase signaling in regulating glial cell biology and neuroinflammation, with implications for Parkinsonian neurodegeneration.

CELL DEATH & DISEASE (2021)

Review Nutrition & Dietetics

Effects of Dietary Food Components on Cognitive Functions in Older Adults

Hitoshi Ozawa et al.

Summary: Population aging is a pressing issue globally due to increasing numbers of elderly individuals and rising social security costs. Cognitive decline in the elderly is a serious problem that requires attention in future care. Dietary patterns may play a role in improving age-related cognitive decline.

NUTRIENTS (2021)

Review Clinical Neurology

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications

Rosie Bell et al.

Summary: This article discusses the features and pathophysiology of Parkinson's disease and related synucleinopathies, emphasizing the potential importance of the dysregulation of lipid homeostasis and alpha-synuclein homeostasis in disease development. It also explores the role of post-translational modifications in modulating the interactions of alpha-synuclein with lipid membranes, and the impact of these advancements on the development of new diagnostic and therapeutic tools.

FRONTIERS IN NEUROLOGY (2021)

Review Cell Biology

Alpha-Synuclein and Lipids: The Elephant in the Room?

Alessia Sarchione et al.

Summary: Studies have shown that α-syn plays a key role in the pathogenesis of PD and other synucleinopathies, with interactions between α-syn and lipids contributing to misfolding and aggregation. Additionally, α-syn is involved in different steps of synaptic exocytosis. The importance of lipids in PD is highlighted by their impact on α-syn metabolism and modulation, as well as genetic determinants associated with lipid homeostasis and α-syn pathologies.
Article Biochemistry & Molecular Biology

An imbalanced ratio between PC(16:0/16:0) and LPC(16:0) revealed by lipidomics supports the role of the Lands cycle in ischemic brain injury

Lifeng Zheng et al.

Summary: The study used a high-sensitivity UPLC-MS method to semi-quantitatively measure lipid changes in the mouse cerebral cortex recovering from a stroke, revealing a strong relationship between phosphatidylcholine reduction and lysophosphatidylcholine increase during reperfusion. The data support the role of imbalanced lipid ratios in neuronal damage and inflammatory responses during stroke recovery.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Chemistry, Applied

The Combined Effects of Lysophospholipids against Lipopolysaccharide-induced Inflammation and Oxidative Stress in Microglial Cells

Tamotsu Tsukahara et al.

Summary: Our study demonstrated that LPC and LPE have significant protective effects against LPS-induced inflammation and oxidative stress in SIM-A9 cells, by inhibiting IL-6 expression and reducing ROS production.

JOURNAL OF OLEO SCIENCE (2021)

Review Neurosciences

Lysophosphatidic Acid Signalling in Nervous System Development and Function

Eric Birgbauer

Summary: Lysophospholipids, particularly lysophosphatidic acid (LPA), play a crucial role in nerve system signaling by activating G protein-coupled receptors (GPCRs) to induce various physiological responses. Aberrant LPA receptor signaling may contribute to neuropathological conditions, with significant clinical implications.

NEUROMOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor

Kseniia Afitska et al.

JOURNAL OF MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

Anne-Laure Mahul-Mellier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Porcine liver decomposition product-derived lysophospholipids promote microglial activation in vitro

Tamotsu Tsukahara et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

Platelets in Neurodegenerative Conditions-Friend or Foe?

Odette Leiter et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Behavioral Sciences

Dietary phospholipids: Role in cognitive processes across the lifespan

Marina Schverer et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)

Review Biochemistry & Molecular Biology

Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms

Justyna Godos et al.

ANTIOXIDANTS (2020)

Article Multidisciplinary Sciences

The hot sites of α-synuclein in amyloid fibril formation

Anahita Khammari et al.

SCIENTIFIC REPORTS (2020)

Review Cell Biology

The Role of Lipids in the Initiation of α-Synuclein Misfolding

Martin Kiechle et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Food Science & Technology

The Link between the Consumer and the Innovations in Food Product Development

Raquel P. F. Guine et al.

Article Physiology

NACore Amyloid Formation in the Presence of Phospholipids

Jon Pallbo et al.

FRONTIERS IN PHYSIOLOGY (2020)

Article Neurosciences

Neurobiological effects of phospholipids in vitro: Relevance to stress-related disorders

Francisco Donoso et al.

NEUROBIOLOGY OF STRESS (2020)

Review Biochemistry & Molecular Biology

Emerging roles of lysophospholipids in health and disease

Shu Ting Tan et al.

PROGRESS IN LIPID RESEARCH (2020)

Review Immunology

Immune Signaling in Neurodegeneration

Timothy R. Hammond et al.

IMMUNITY (2019)

Review Biochemistry & Molecular Biology

How is alpha-synuclein cleared from the cell?

Leonidas Stefanis et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Review Cell Biology

Microglia-mediated neuroinflammation in neurodegenerative diseases

Charannya Sozheesvari Subhramanyam et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)

Review Neurosciences

Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors

Lisandro Jorge Falomir-Lockhart et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Editorial Material Clinical Neurology

Alpha-synuclein: prion or prion-like?

Rehana K. Leak et al.

ACTA NEUROPATHOLOGICA (2019)

Article Multidisciplinary Sciences

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling

Akio Mori et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Pharmacology & Pharmacy

Neuroinflammation as a Common Feature of Neurodegenerative Disorders

Leonardo Guzman-Martinez et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP+-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons

Ichiro Kawahata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Anatomy & Morphology

Expression of -synuclein is regulated in a neuronal cell type-dependent manner

Katsutoshi Taguchi et al.

ANATOMICAL SCIENCE INTERNATIONAL (2019)

Review Biochemistry & Molecular Biology

The Cellular Environment Affects Monomeric α-Synuclein Structure

Amberley D. Stephens et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Article Chemistry, Multidisciplinary

Structure-based inhibitors of tau aggregation

P. M. Seidler et al.

NATURE CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Nucleic acid aptamers for neurodegenerative diseases

Alix Bouvier-Muller et al.

BIOCHIMIE (2018)

Review Neurosciences

Impact of Dietary Fats on Brain Functions

Rosanna Chianese et al.

CURRENT NEUROPHARMACOLOGY (2018)

Review Neurosciences

Mitochondria and Mitochondrial Cascades in Alzheimer's Disease

Russell H. Swerdlow

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Biology

Cryo-EM structure of alpha-synuclein fibrils

Ricardo Guerrero-Ferreira et al.

Review Neurosciences

Import and Export of Misfoldeda alpha-Synuclein

Lilia Rodriguez et al.

FRONTIERS IN NEUROSCIENCE (2018)

Review Neurosciences

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease

Jessika C. Bridi et al.

FRONTIERS IN NEUROSCIENCE (2018)

Review Biochemistry & Molecular Biology

Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds

Seyed Khosrow Tayebati

MOLECULES (2018)

Review Pharmacology & Pharmacy

NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease

J. Haslund-Vinding et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Studies on diagnostic biomarkers and therapeutic mechanism of Alzheimer's disease through metabolomics and hippocampal proteomics

Weiwei Lin et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Article Biochemistry & Molecular Biology

Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain

Antonio Currais et al.

FASEB JOURNAL (2017)

Review Neurosciences

The Synucleinopathies: Twenty Years On

Michel Goedert et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Article Neurosciences

Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates

Shigeki Arawaka et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation

Sanja Curcic et al.

SCIENTIFIC REPORTS (2017)

Article Pharmacology & Pharmacy

Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases

Chiara Giacomelli et al.

BIOCHEMICAL PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization

Filsy Samuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Review Biochemistry & Molecular Biology

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

Myles R. Minter et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Cell Biology

α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity

Zhaoyang Hu et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)

Article Neurosciences

Nutraceuticals against Neurodegeneration: A Mechanistic Insight

Vivekkumar P. Dadhania et al.

CURRENT NEUROPHARMACOLOGY (2016)

Review Medicine, General & Internal

Alpha-synuclein structure, functions, and interactions

Fatemeh Nouri Emamzadeh

JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2016)

Review Neurosciences

Versatile Structures of α-Synuclein

Chuchu Wang et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)

Article Agriculture, Dairy & Animal Science

Effect of emulsifier (lysophospholipids) on growth performance, nutrient digestibility and blood profile in weanling pigs

P. Y. Zhao et al.

ANIMAL FEED SCIENCE AND TECHNOLOGY (2015)

Article Biochemistry & Molecular Biology

Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation

Celine Galvagnion et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS

Michiyo Okudaira et al.

JOURNAL OF LIPID RESEARCH (2014)

Article Chemistry, Multidisciplinary

The Presence of an Air-Water Interface Affects Formation and Elongation of α-Synuclein Fibrils

Silvia Campioni et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Review Neurosciences

Alpha-synuclein and tau: teammates in neurodegeneration?

Simon Moussaud et al.

MOLECULAR NEURODEGENERATION (2014)

Article Multidisciplinary Sciences

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

Long N. Nguyen et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

Plasma phospholipids identify antecedent memory impairment in older adults

Mark Mapstone et al.

NATURE MEDICINE (2014)

Article Clinical Neurology

Alpha-synuclein biology in Lewy body diseases

Woojin Scott Kim et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Review Biochemistry & Molecular Biology

Novel bioactive glycerol-based lysophospholipids: New data - New insight into their function

Anna Grzelczyk et al.

BIOCHIMIE (2013)

Article Geriatrics & Gerontology

Risk Factors for the Progression of Mild Cognitive Impairment to Dementia

Noll L. Campbell et al.

CLINICS IN GERIATRIC MEDICINE (2013)

Review Pharmacology & Pharmacy

Insights into the pharmacological relevance of lysophospholipid receptors

Tetsuji Mutoh et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Article Biochemistry & Molecular Biology

Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein

Nunilo Cremades et al.

Article Biochemistry & Molecular Biology

Resveratrol mitigates lipopolysaccharide- and Aß-mediated microglial inflammation by inhibiting the TLR4/NF-?B/STAT signaling cascade

Hemachander Capiralla et al.

JOURNAL OF NEUROCHEMISTRY (2012)

Article Neurosciences

Exosomal cell-to-cell transmission of alpha synuclein oligomers

Karin M. Danzer et al.

MOLECULAR NEURODEGENERATION (2012)

Article Biochemistry & Molecular Biology

Fatty acid transport into the brain: Of fatty acid fables and lipid tails

Ryan W. Mitchell et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)

Review Biochemistry & Molecular Biology

Synthesis of Lysophospholipids

Paola D'Arrigo et al.

MOLECULES (2010)

Review Biochemistry & Molecular Biology

Metalloproteomics and metal toxicology of alpha-synuclein

Aaron Santner et al.

METALLOMICS (2010)

Article Clinical Neurology

Early Diagnosis of Alzheimer's Disease: Is MCI Too Late?

Ronald C. Petersen

CURRENT ALZHEIMER RESEARCH (2009)

Review Neurosciences

Brain foods:: the effects of nutrients on brain function

Fernando Gomez-Pinilla

NATURE REVIEWS NEUROSCIENCE (2008)

Article Geriatrics & Gerontology

Synuclein activates microglia in a model of Parkinson's disease

Xiaomin Su et al.

NEUROBIOLOGY OF AGING (2008)

Article Biochemistry & Molecular Biology

Molecular anatomy of a trafficking organelle

Shigeo Takamori et al.

Article Clinical Neurology

Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia

Carmen Cristea Janvin et al.

MOVEMENT DISORDERS (2006)

Article Biochemical Research Methods

Quantification of lysophosphatidylcholines and phosphatidylcholines using liquid chromatography-tandem mass spectrometry in neonatal serum

Akihiro Takatera et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)

Article Clinical Neurology

How to diagnose dementia with Lewy bodies: State of the art

F Geser et al.

MOVEMENT DISORDERS (2005)

Article Multidisciplinary Sciences

Structural characterization of copper(II) binding to α-synuclein:: Insights into the bioinorganic chemistry of Parkinson's disease

RM Rasia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Ubiquitination of α-synuclein

T Nonaka et al.

BIOCHEMISTRY (2005)

Article Biochemistry & Molecular Biology

The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils

M Zhu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation

CO Fernández et al.

EMBO JOURNAL (2004)

Article Biochemistry & Molecular Biology

Lipid binding inhibits α-synuclein fibril formation

M Zhu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Cellular polyamines promote the aggregation of α-synuclein

T Antony et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions

M Hasegawa et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Endocrinology & Metabolism

A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures

N Blondeau et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)

Article Biochemistry & Molecular Biology

Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein

NB Cole et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Endocrinology & Metabolism

Long-chain polyunsaturated fatty acid accretion in brain

KM Qi et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2002)

Article Biochemistry & Molecular Biology

Chaperone-like properties of lysophospholipids

R Kern et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Biochemistry & Molecular Biology

Membrane binding and self-association of α-synucleins

V Narayanan et al.

BIOCHEMISTRY (2001)

Review Clinical Neurology

Synucleinopathies - Clinical and pathological implications

JE Galvin et al.

ARCHIVES OF NEUROLOGY (2001)

Article Biochemistry & Molecular Biology

α-synuclein membrane interactions and lipid specificity

EJ Jo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Biochemistry & Molecular Biology

Constitutive phosphorylation of the Parkinson's disease associated α-synuclein

M Okochi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)